Barrington upgrades Landec (LNDC) to a Buy

Landec (LNDCResearch Report) received a Buy rating and a $14.00 price target from Barrington analyst Michael Petusky today. The company’s shares closed yesterday at $11.02.

According to TipRanks, Petusky is a 4-star analyst with an average return of 8.5% and a 51.38% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Lemaitre Vascular, Option Care Health, and Merit Medical Systems.

Currently, the analyst consensus on Landec is a Moderate Buy with an average price target of $13.50.

See the top stocks recommended by analysts >>

The company has a one-year high of $12.04 and a one-year low of $7.65. Currently, Landec has an average volume of 64.87K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Curation Foods, Lifecore, and Others. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Clara, CA.

Read More on LNDC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More